Search results

Found 51 pages
AUTHOR: Hugh Gosling

Results per page

10 20 50 100

Sort by

Relevance Date

1 Jan 2016:

2015: How was it for you? - PharmaTimes Magazine January 2016

2016 has arrived, but was 2015 a good year for you, your company and your industry? - Magazine Article - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/magazine/2016/january_2016/2015_how_was_it_for_you

27 Jul 2016:

Nerve stimulation reduces impact of migraine

A pilot study has shown that non-invasive vagus nerve stimulation (nVNS) reduced the number of headache days per month for chronic migraine patients. - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/nerve_stimulation_reduces_impact_of_migraine_1082844

8 Apr 2016:

England's pledge to recruit more GPs failing

Health secretary Jeremy Hunt’s plans to bring as many 400 doctors from India to the UK are an “admission of failure” of its recruitment policies, says the BMA. - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/englands_pledge_to_recruit_more_gps_failing_1020509

1 Jan 2016:

Accelerated access? - PharmaTimes Magazine January 2016

2015 saw the arrival of some truly innovative new medicines with the promise of totally transforming some disease areas. - Magazine Article - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/magazine/2016/january_2016/accelerated_access

27 May 2016:

June issue of PharmaTimes - out now

Read the June issue of PharmaTimes now - digital and online. - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/june_issue_of_pharmatimes_-_out_now_1030811

10 Dec 2015:

EMA head outlines five-year plan

The EMA is ready to address the challenges ahead, according to the agency’s incoming executive director Professor Guido Rasi, who has outlined his vision for the next five years. - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/ema_head_outlines_five-year_plan_972260

1 Jan 2016:

Compliance complacency? - PharmaTimes Magazine January 2016

Companies can transform their compliance function from a burden to a benefit, concludes a report from Deloitte’s Centre for Health Solutions - Magazine Article - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/magazine/2016/january_2016/compliance_complacency

21 Dec 2015:

93 medicines recommended by CHMP in 2015

Nine new medicines were recommended for marketing approval at the last meeting of the of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), bringing the total to 93 for 2015. - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/93_medicines_recommended_by_chmp_in_2015_972300

22 Dec 2015:

New 'nectar-like' oral formulation for vital ALS drug

The launch of the first liquid form of Martindale’s Teglutik (riluzole) has been welcomed by healthcare professionals as a “great benefit” for patients with motor neurone disease (MND). - News - PharmaTimes

by Hugh Gosling

https://www.pharmatimes.com/news/new_nectar-like_oral_formulation_for_vital_als_drug_972304

29 Oct 2015:

Pfizer eyes up Allergan

Pfizer is in preliminary talks to take over Allergan, according to reports from the Wall Street Journal and Financial Times. The unconfirmed reports follow contact between Pfizer head Ian Read and his counterpart at Allergan, Brent Saunders. - News -

by Hugh Gosling

https://www.pharmatimes.com/news/pfizer_eyes_up_allergan_972075